BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis

Withdrawn

Conditions: UVeitis
Glaucoma

First Posted Date: 2015-11-24

Last Posted Date: 2023-08-14

Lead Sponsor: University of Nebraska

Registration Number: NCT02613442

Optimal Stent Selection for the Femoropopliteal Artery

Terminated

Conditions: Femoropopliteal Stenting

Interventions: Other: follow-up CTA

First Posted Date: 2015-11-11

Last Posted Date: 2023-08-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 5

Registration Number: NCT02602145

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Balance Training for Elders With Heart Failure

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Balance Intervention

First Posted Date: 2015-10-02

Last Posted Date: 2023-09-25

Lead Sponsor: University of Nebraska

Target Recruit Count: 33

Registration Number: NCT02566785

Locations: 🇺🇸
University of Nebraska Medical Center, College of Nursing, Lincoln, Nebraska, United States

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Phase 1

Completed

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive
Anaplastic Large Cell Lymphoma, ALK-Negative
Stage II Angioimmunoblastic T-cell Lymphoma
Stage IV Enteropathy-Associated T-Cell Lymphoma
Stage III Angioimmunoblastic T-cell Lymphoma
Stage IV Angioimmunoblastic T-cell Lymphoma
Stage II Enteropathy-Associated T-Cell Lymphoma
Hepatosplenic T-Cell Lymphoma
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Stage III Enteropathy-Associated T-Cell Lymphoma

Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation
Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Drug: Etoposide
Other: Laboratory Biomarker Analysis
Drug: Lenalidomide
Procedure: Peripheral Blood Stem Cell Transplantation
Drug: Prednisone
Drug: Vincristine Sulfate

First Posted Date: 2015-09-28

Last Posted Date: 2023-12-13

Lead Sponsor: University of Nebraska

Target Recruit Count: 54

Registration Number: NCT02561273

Locations: 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸
Stanford Cancer Institute, Palo Alto, California, United States
🇺🇸
University of Colorado Cancer Center, Anschutz Cancer Pavilion, Aurora, Colorado, United States

and more 5 locations

Simplified Diet Approach in Phenylketonuria

Not Applicable

Completed

Conditions: Phenylketonuria

Interventions: Behavioral: Dietary Protein Counting and Free Fruits and Vegetables

First Posted Date: 2015-09-21

Last Posted Date: 2023-09-07

Lead Sponsor: University of Nebraska

Target Recruit Count: 33

Registration Number: NCT02555579

Locations: 🇺🇸
Monroe-Meyer Insititute, Omaha, Nebraska, United States
🇺🇸
Children's Hospital & Medical Center, Omaha, Nebraska, United States
🇺🇸
Nebraska Medicine, Midtown Health Center, Omaha, Nebraska, United States

and more 1 locations

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Not Applicable

Active, not recruiting

Conditions: Chronic Lymphocytic Leukemia
Untreated Chronic Lymphocytic Leukemia
Non-Hodgkin Lymphoma
Vitamin D Deficiency

Interventions: Dietary Supplement: Cholecalciferol
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-09-17

Last Posted Date: 2024-10-08

Lead Sponsor: University of Nebraska

Target Recruit Count: 197

Registration Number: NCT02553447

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 2

Terminated

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Capecitabine
Drug: Docetaxel
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2015-08-14

Last Posted Date: 2023-09-08

Lead Sponsor: University of Nebraska

Target Recruit Count: 14

Registration Number: NCT02524275

Locations: 🇺🇸
Faith Regional Health Services Carson Cancer Center, Norfolk, Nebraska, United States
🇺🇸
Omaha Veterans Administration Medical Center, Omaha, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Influence of Exercise on the Mobility and Balance of Individuals With Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Behavioral: Therapeutic Exercise Program
Behavioral: Therapeutic Challenge Program

First Posted Date: 2015-08-14

Last Posted Date: 2023-09-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 32

Registration Number: NCT02524483

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Monroe-Meyer Institute, Omaha, Nebraska, United States

Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study

Phase 2

Withdrawn

Conditions: Diabetic Macular Edema

Interventions: Drug: Ranibizumab
Drug: Tocilizumab

First Posted Date: 2015-07-29

Last Posted Date: 2023-08-15

Lead Sponsor: University of Nebraska

Registration Number: NCT02511067

Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control

Not Applicable

Terminated

Conditions: Aggression
Self-Injurious Behavior

Interventions: Behavioral: Functional Communication Training

First Posted Date: 2015-06-29

Last Posted Date: 2023-09-18

Lead Sponsor: University of Nebraska

Target Recruit Count: 4

Registration Number: NCT02483572

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

AI-Powered Research

Premium Access

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis

Optimal Stent Selection for the Femoropopliteal Artery

Balance Training for Elders With Heart Failure

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Simplified Diet Approach in Phenylketonuria

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Influence of Exercise on the Mobility and Balance of Individuals With Multiple Sclerosis

Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study

Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control